An impressive 79% reduction in HIV incidence was seen between two directly comparable groups in a whole-population analysis from Australia, presented to the Conference on Retroviruses and Opportunistic Infections (CROI 2024) this week by Dr Nicholas Medland.
People who have received hepatitis C treatment and who were not adherent to PrEP were particularly vulnerable to acquiring HIV within a few years of receiving their first PrEP prescription.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
-
EL PAÍS: US aid cuts collapse Malawi’s LGBTQ+ health services as volunteers scramble to fill the void
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.